Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial

Kathryn L. Taylor, Charlotte J. Hagerman, George Luta, Paula G. Bellini, Cassandra Stanton, David Brian Abrams, Jenna A. Kramer, Eric Anderson, Shawn Regis, Andrea McKee, Brady McKee, Ray Niaura, Harry Harper, Michael Ramsaier

Research output: Contribution to journalArticle

Abstract

Incorporating effective smoking cessation interventions into lung cancer screening (LCS) programs will be essential to realizing the full benefit of screening. We conducted a pilot randomized trial to determine the feasibility and efficacy of a telephone-counseling (TC) smoking cessation intervention vs. usual care (UC) in the LCS setting. In collaboration with 3 geographically diverse LCS programs, we enrolled current smokers (61.5% participation rate) who were: registered to undergo LCS, 50-77 years old, and had a 20+ pack-year smoking history. Eligibility was not based on readiness to quit. Participants completed pre-LCS (T0) and post-LCS (T1) telephone assessments, were randomized to TC (N = 46) vs. UC (N = 46), and completed a final 3-month telephone assessment (T2). Both study arms received a list of evidence-based cessation resources. TC participants also received up to 6 brief counseling calls with a trained cessation counselor. Counseling calls incorporated motivational interviewing and utilized the screening result as a motivator for quitting. The outcome was biochemically verified 7-day point prevalence cessation at 3-months post-randomization. Participants (56.5% female) were 60.2 (SD = 5.4) years old and reported 47.1 (SD = 22.2) pack years; 30% were ready to stop smoking in the next 30 days. TC participants completed an average of 4.4 (SD = 2.3) sessions. Using intent-to-treat analyses, biochemically verified quit rates were 17.4% (TC) vs. 4.3% (UC), p <. .05. This study provides preliminary evidence that telephone-based cessation counseling is feasible and efficacious in the LCS setting. As millions of current smokers are now eligible for lung cancer screening, this setting represents an important opportunity to exert a large public health impact on cessation among smokers who are at very high risk for multiple tobacco-related diseases. If this evidence-based, brief, and scalable intervention is replicated, TC could help to improve the overall cost-effectiveness of LCS. Trial registration: NCT02267096, https://clinicaltrials.gov

Original languageEnglish (US)
JournalLung Cancer
DOIs
StateAccepted/In press - Oct 13 2016
Externally publishedYes

Fingerprint

Smoking Cessation
Early Detection of Cancer
Telephone
Counseling
Lung Neoplasms
Randomized Controlled Trials
Smoking
Motivational Interviewing
Random Allocation
Tobacco
Cost-Benefit Analysis
Public Health
History

Keywords

  • Lung cancer screening
  • Randomized trial
  • Smoking cessation
  • Telephone counseling

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting : A randomized clinical trial. / Taylor, Kathryn L.; Hagerman, Charlotte J.; Luta, George; Bellini, Paula G.; Stanton, Cassandra; Abrams, David Brian; Kramer, Jenna A.; Anderson, Eric; Regis, Shawn; McKee, Andrea; McKee, Brady; Niaura, Ray; Harper, Harry; Ramsaier, Michael.

In: Lung Cancer, 13.10.2016.

Research output: Contribution to journalArticle

Taylor, KL, Hagerman, CJ, Luta, G, Bellini, PG, Stanton, C, Abrams, DB, Kramer, JA, Anderson, E, Regis, S, McKee, A, McKee, B, Niaura, R, Harper, H & Ramsaier, M 2016, 'Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial', Lung Cancer. https://doi.org/10.1016/j.lungcan.2017.01.020
Taylor, Kathryn L. ; Hagerman, Charlotte J. ; Luta, George ; Bellini, Paula G. ; Stanton, Cassandra ; Abrams, David Brian ; Kramer, Jenna A. ; Anderson, Eric ; Regis, Shawn ; McKee, Andrea ; McKee, Brady ; Niaura, Ray ; Harper, Harry ; Ramsaier, Michael. / Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting : A randomized clinical trial. In: Lung Cancer. 2016.
@article{118331615d6045dd923c782a4d0c7d85,
title = "Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting: A randomized clinical trial",
abstract = "Incorporating effective smoking cessation interventions into lung cancer screening (LCS) programs will be essential to realizing the full benefit of screening. We conducted a pilot randomized trial to determine the feasibility and efficacy of a telephone-counseling (TC) smoking cessation intervention vs. usual care (UC) in the LCS setting. In collaboration with 3 geographically diverse LCS programs, we enrolled current smokers (61.5{\%} participation rate) who were: registered to undergo LCS, 50-77 years old, and had a 20+ pack-year smoking history. Eligibility was not based on readiness to quit. Participants completed pre-LCS (T0) and post-LCS (T1) telephone assessments, were randomized to TC (N = 46) vs. UC (N = 46), and completed a final 3-month telephone assessment (T2). Both study arms received a list of evidence-based cessation resources. TC participants also received up to 6 brief counseling calls with a trained cessation counselor. Counseling calls incorporated motivational interviewing and utilized the screening result as a motivator for quitting. The outcome was biochemically verified 7-day point prevalence cessation at 3-months post-randomization. Participants (56.5{\%} female) were 60.2 (SD = 5.4) years old and reported 47.1 (SD = 22.2) pack years; 30{\%} were ready to stop smoking in the next 30 days. TC participants completed an average of 4.4 (SD = 2.3) sessions. Using intent-to-treat analyses, biochemically verified quit rates were 17.4{\%} (TC) vs. 4.3{\%} (UC), p <. .05. This study provides preliminary evidence that telephone-based cessation counseling is feasible and efficacious in the LCS setting. As millions of current smokers are now eligible for lung cancer screening, this setting represents an important opportunity to exert a large public health impact on cessation among smokers who are at very high risk for multiple tobacco-related diseases. If this evidence-based, brief, and scalable intervention is replicated, TC could help to improve the overall cost-effectiveness of LCS. Trial registration: NCT02267096, https://clinicaltrials.gov",
keywords = "Lung cancer screening, Randomized trial, Smoking cessation, Telephone counseling",
author = "Taylor, {Kathryn L.} and Hagerman, {Charlotte J.} and George Luta and Bellini, {Paula G.} and Cassandra Stanton and Abrams, {David Brian} and Kramer, {Jenna A.} and Eric Anderson and Shawn Regis and Andrea McKee and Brady McKee and Ray Niaura and Harry Harper and Michael Ramsaier",
year = "2016",
month = "10",
day = "13",
doi = "10.1016/j.lungcan.2017.01.020",
language = "English (US)",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Preliminary evaluation of a telephone-based smoking cessation intervention in the lung cancer screening setting

T2 - A randomized clinical trial

AU - Taylor, Kathryn L.

AU - Hagerman, Charlotte J.

AU - Luta, George

AU - Bellini, Paula G.

AU - Stanton, Cassandra

AU - Abrams, David Brian

AU - Kramer, Jenna A.

AU - Anderson, Eric

AU - Regis, Shawn

AU - McKee, Andrea

AU - McKee, Brady

AU - Niaura, Ray

AU - Harper, Harry

AU - Ramsaier, Michael

PY - 2016/10/13

Y1 - 2016/10/13

N2 - Incorporating effective smoking cessation interventions into lung cancer screening (LCS) programs will be essential to realizing the full benefit of screening. We conducted a pilot randomized trial to determine the feasibility and efficacy of a telephone-counseling (TC) smoking cessation intervention vs. usual care (UC) in the LCS setting. In collaboration with 3 geographically diverse LCS programs, we enrolled current smokers (61.5% participation rate) who were: registered to undergo LCS, 50-77 years old, and had a 20+ pack-year smoking history. Eligibility was not based on readiness to quit. Participants completed pre-LCS (T0) and post-LCS (T1) telephone assessments, were randomized to TC (N = 46) vs. UC (N = 46), and completed a final 3-month telephone assessment (T2). Both study arms received a list of evidence-based cessation resources. TC participants also received up to 6 brief counseling calls with a trained cessation counselor. Counseling calls incorporated motivational interviewing and utilized the screening result as a motivator for quitting. The outcome was biochemically verified 7-day point prevalence cessation at 3-months post-randomization. Participants (56.5% female) were 60.2 (SD = 5.4) years old and reported 47.1 (SD = 22.2) pack years; 30% were ready to stop smoking in the next 30 days. TC participants completed an average of 4.4 (SD = 2.3) sessions. Using intent-to-treat analyses, biochemically verified quit rates were 17.4% (TC) vs. 4.3% (UC), p <. .05. This study provides preliminary evidence that telephone-based cessation counseling is feasible and efficacious in the LCS setting. As millions of current smokers are now eligible for lung cancer screening, this setting represents an important opportunity to exert a large public health impact on cessation among smokers who are at very high risk for multiple tobacco-related diseases. If this evidence-based, brief, and scalable intervention is replicated, TC could help to improve the overall cost-effectiveness of LCS. Trial registration: NCT02267096, https://clinicaltrials.gov

AB - Incorporating effective smoking cessation interventions into lung cancer screening (LCS) programs will be essential to realizing the full benefit of screening. We conducted a pilot randomized trial to determine the feasibility and efficacy of a telephone-counseling (TC) smoking cessation intervention vs. usual care (UC) in the LCS setting. In collaboration with 3 geographically diverse LCS programs, we enrolled current smokers (61.5% participation rate) who were: registered to undergo LCS, 50-77 years old, and had a 20+ pack-year smoking history. Eligibility was not based on readiness to quit. Participants completed pre-LCS (T0) and post-LCS (T1) telephone assessments, were randomized to TC (N = 46) vs. UC (N = 46), and completed a final 3-month telephone assessment (T2). Both study arms received a list of evidence-based cessation resources. TC participants also received up to 6 brief counseling calls with a trained cessation counselor. Counseling calls incorporated motivational interviewing and utilized the screening result as a motivator for quitting. The outcome was biochemically verified 7-day point prevalence cessation at 3-months post-randomization. Participants (56.5% female) were 60.2 (SD = 5.4) years old and reported 47.1 (SD = 22.2) pack years; 30% were ready to stop smoking in the next 30 days. TC participants completed an average of 4.4 (SD = 2.3) sessions. Using intent-to-treat analyses, biochemically verified quit rates were 17.4% (TC) vs. 4.3% (UC), p <. .05. This study provides preliminary evidence that telephone-based cessation counseling is feasible and efficacious in the LCS setting. As millions of current smokers are now eligible for lung cancer screening, this setting represents an important opportunity to exert a large public health impact on cessation among smokers who are at very high risk for multiple tobacco-related diseases. If this evidence-based, brief, and scalable intervention is replicated, TC could help to improve the overall cost-effectiveness of LCS. Trial registration: NCT02267096, https://clinicaltrials.gov

KW - Lung cancer screening

KW - Randomized trial

KW - Smoking cessation

KW - Telephone counseling

UR - http://www.scopus.com/inward/record.url?scp=85012903675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012903675&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2017.01.020

DO - 10.1016/j.lungcan.2017.01.020

M3 - Article

C2 - 28216065

AN - SCOPUS:85012903675

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -